Venous Thromboembolism in Blood or Marrow Transplant (BMT) Survivors: A Report from BMT Survivor Study (BMTSS)

CONCLUSION: BMT survivors are at a 2.8-fold increased risk of developing VTE when compared with a non-BMT sibling comparison group. Those with VTE are at an increased risk of subsequent NRM. Development of risk prediction models to identify BMT survivors at highest risk would facilitate targeted thromboprophylaxis.DisclosuresWeisdorf: Equillium: Consultancy; SL Behring: Consultancy; Seattle Genetics: Consultancy; FATE: Consultancy; Pharmacyclics: Consultancy. Forman: Mustang Therapeutics: Other: Licensing Agreement, Patents & Royalties, Research Funding.

Source: Blood - November 21, 2018 Category: Hematology Authors: Gangaraju, R., Chen, Y., Hageman, L., Wu, J., Francisco, L. F., Kung, M., Ness, E., Parman, M., Weisdorf, D. J., Forman, S. J., Arora, M., Armenian, S. H., Bhatia, S. Tags: 901. Health Services Research-Non-Malignant Conditions: Bone Marrow Transplantation and Benign Hematology Source Type: research